EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Resource‐Adapted Triage Strategies for Women Testing HPV Positive With Self‐Collected Vaginal Samples in Cameroon

Micol Murtas iD, Pierre Vassilakos, Ania Wisniak, Ketty Hu, Marc Arbyn iD, Gilles W Tankeu Happi, Esther Abatsong, François Marcel Ndam Nsangou, Jean-Christophe Tille, Essia Saiji, Bruno Kenfack, Patrick Petignat

International Journal of Cancer · 15.10.2026 · 159 (8) · 1949-1961

DOI: 10.1002/ijc.70573 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 18.06.2026. Verfasst von Micol Murtas und 11 weiteren Autor:innen. Beteiligte Einrichtung: Gynecologic Division, Department of Pediatrics, Gynecology, and Obstetrics, University Hospitals Geneva, University of Geneva, Geneva, Switzerland. Hauptthemen laut MEDLINE: Papillomavirus Infections, Triage, Uterine Cervical Neoplasms, Uterine Cervical Dysplasia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Geneva, Swiss Cancer Research Foundation, Université de Genève.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The World Health Organization (WHO) recommends HPV‐DNA testing as the primary screening method for cervical cancer in low‐ and middle‐income countries (LMICs), yet guidance on how to triage HPV‐positive women remains limited. The 2021 WHO guidelines for LMICs do not incorporate extended HPV genotyping, despite its potential to improve risk stratification and support scalable management strategies. This study evaluated screening strategies based on locally available resources for management of HPV‐positive women. We retrospectively analyzed data from the 3T study (Test, Triage, and Treat), conducted between 2018 and 2022, which included HPV self‐sampling and VIA triage among women aged 30–49 years. For all HPV‐positive participants, HPV testing (stratified into five genotype‐based risk groups), cytology, VIA, cervical‐biopsy, and endocervical‐brush histopathology were available. Thirty‐five screening and triage strategies integrating HPV extended genotyping alone or in combination with VIA or cytology were assessed using CIN3+ risk as a guiding principle. Among 868 HPV‐positive women, 9% had CIN3+ lesions. HPV types 31/33/35/52/58 were most prevalent, whereas HPV16 and HPV18/45 carried the highest CIN3+ risks. Strategies combining extended genotyping with cytology demonstrated the best balance of sensitivity and specificity. In settings without access to cytology or VIA, direct treatment of the eight highest‐risk HPV types, 16/18/45/31/33/35/52/58, showed the best balance between sensitivity and specificity. When cytology or VIA was available, immediate treatment for HPV16 and reflex triage, cytology (treating ≥ ASCUS lesions), or VIA for HPV18/45/31/33/35/52/58 showed the best trade‐off. The proposed screening strategies enable risk‐adapted triage and guide management decisions based on available resources.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsTriageUterine Cervical NeoplasmsUterine Cervical DysplasiaPapillomaviridaeHuman Papillomavirus VirusesHumansFemaleMiddle AgedAdultCameroonRetrospective StudiesEarly Detection of CancerGenotypeVaginal SmearsSpecimen HandlingDNA, Viral

Stichwörter der Autor:innen

cervical cancer screeningextended genotypinghuman papillomavirusresource‐adapted strategiesrisk‐based management

Substanzen

DNA, Viral

Autor:innen und Institutionen

  • Gynecologic Division, Department of Pediatrics, Gynecology, and Obstetrics, University Hospitals Geneva, University of Geneva, Geneva, Switzerland.
  • Geneva Foundation for Medical Education and Research, Geneva, Switzerland.
  • Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Unit of Cancer Epidemiology, Belgian Cancer Centre, Brussels, Belgium.
  • Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, University of Ghent, Ghent, Belgium.
  • Department of Gynaecology and Obstetrics, Dschang Regional Annex Hospital, Dschang, Cameroon.

ORCID-Profile: Micol Murtas, Marc Arbyn

Förderung

  • University of Geneva
  • Swiss Cancer Research Foundation
  • Université de Genève

Zitieren

APA

Murtas, M., Vassilakos, P., Wisniak, A., Hu, K., Arbyn, M., Tankeu Happi, G. W., Abatsong, E., Nsangou, F. M. N., Tille, J. C., Saiji, E., Kenfack, B., & Petignat, P. (2026). Resource‐Adapted Triage Strategies for Women Testing HPV Positive With Self‐Collected Vaginal Samples in Cameroon. International Journal of Cancer, 159(8), 1949-1961. https://doi.org/10.1002/ijc.70573

Vancouver

Murtas M, Vassilakos P, Wisniak A, Hu K, Arbyn M, Tankeu Happi GW, et al. Resource‐Adapted Triage Strategies for Women Testing HPV Positive With Self‐Collected Vaginal Samples in Cameroon. International Journal of Cancer. 2026;159(8):1949-1961. doi:10.1002/ijc.70573

BibTeX
@article{Murtas2026,
  author = {Murtas, Micol and Vassilakos, Pierre and Wisniak, Ania and Hu, Ketty and Arbyn, Marc and Tankeu Happi, Gilles W and Abatsong, Esther and Nsangou, François Marcel Ndam and Tille, Jean-Christophe and Saiji, Essia and Kenfack, Bruno and Petignat, Patrick},
  title = {Resource‐Adapted Triage Strategies for Women Testing HPV Positive With Self‐Collected Vaginal Samples in Cameroon},
  journal = {International Journal of Cancer},
  year = {2026},
  volume = {159},
  number = {8},
  pages = {1949--1961},
  doi = {10.1002/ijc.70573}
}
Kostenlos starten →